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ABSTRACT
Objectives: The objective of present systematic review was to test the hypothesis of no difference in histomorphometric 
outcome after maxillary sinus floor augmentation with autogenous bone graft alone compared with alternate grafting materials 
applying the lateral window technique.
Material and Methods: MEDLINE (PubMed), Embase and Cochrane library search in combination with hand-search 
of relevant journals were conducted. Human studies published in English until the 25th of March, 2020 were included. 
Histomorphometric outcomes were evaluated by descriptive statistics and meta-analysis including 95% confidence interval (CI).
Results: Electronic search and hand-searching resulted in 1902 entries. Sixteen randomized controlled trials with unclear risk 
of bias fulfilled the inclusion criteria. Descriptive statistics showed comparable or improved histomorphometric outcomes 
with autogenous bone graft. Meta-analysis revealed a mean difference of -7.1% (CI = -11.0 to -3.2) indicating a significant 
higher amount of bone after maxillary sinus floor augmentation with autogenous bone graft compared with alternate grafting 
materials. Subgroup analysis demonstrated a non-significantly differences of -3.7% (CI = -10.9 to 3.4), -11.5% (CI = -25.9 
to 2.8), 2.2% (CI = -16.9 to 21.3), and -4.6% (CI = -14.4 to 5.2), when autogenous bone graft was compared with allogeneic 
bone graft, xenograft, composite grafting materials involving xenograft or synthetic biomaterial mixed with autogenous bone 
graft, respectively.
Conclusions: Maxillary sinus floor augmentation with autogenous bone graft seems to facilitate improved histomorphometric 
outcomes compared with alternate grafting materials. However, the included studies were characterised by an unclear risk of 
bias and various methodological confounding factors. Hence, the conclusions drawn from the results of present study should 
be interpreted with caution.
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INTRODUCTION
Maxillary sinus floor augmentation (MSFA) was 
originally developed by Tatum in the mid-seventies 
and afterwards described by Boyne and James in 1980 
[1,2]. Nowadays, MSFA applying the lateral window 
technique is the most commonly used surgical 
procedure to increase the vertical alveolar bone height 
of the posterior maxilla before or in conjunction 
with placement of dental implants, and the treatment 
outcome involving various types of grafting materials 
have been documented in systematic reviews and 
meta-analyses [3-10]. Autogenous bone graft is 
generally considered the preferred grafting material 
for MSFA due to its osteoinductive, osteogenic and 
osteoconductive characteristics [11]. Long-term 
studies have demonstrated high survival rates of 
suprastructures and implants, limited peri-implant 
marginal bone loss and few complications after 
MSFA with autogenous bone graft [12,13]. However, 
harvesting of autogenous bone graft is associated 
with risk of donor site morbidity and prolonged 
treatment time [14,15]. Various bone substitutes 
of biologic or synthetic origin are therefore used 
increasingly to simplify the surgical procedure 
by diminishing the need for bone harvesting [4]. 
On the contrary, allogeneic bone graft, synthetic 
biomaterials or bone substitutes of natural transplants 
involves a risk of contamination, activation of host 
immune system and disease transmission as well 
as they can be refused by patients for religious 
reasons or because they are in contrast with chosen 
lifestyle. Thus, selection of the most appropriate 
grafting material for MSFA sustains a matter of 
controversy.
Impaired bone quality and quantity is detrimental to 
obtaining adequate osseointegration of implants in 
the posterior part of the maxilla [16]. MSFA with the 
use of a grafting material facilitates bone regeneration 
and increases bone volume, which enhances the 
potential for achieving sufficient bone-to-implant 
contact (BIC) and long-term implant survival [17]. 
Histomorphometric analysis of tissue specimens or 
micro-computed tomography are the most commonly 
applied methods for assessing percentage of newly 
formed bone, non-mineralized tissue, residual 
grafting material and BIC. Histomorphometric 
parameters are frequently presented as total bone 
volume (TBV), bone area fraction (BAF) or newly 
formed bone, non-mineralized tissue and residual 
graft material in a clearly specified region of interest. 
Experimental studies evaluating histomorphometric 
variables and BIC after MSFA with autogenous 
bone graft compared with various grafting materials 
have revealed disputing results, without significantly 
beneficial histomorphometric characteristics 
with any of the used grafting materials [17-25]. 
A recent published systematic review and meta-
analysis assessing MSFA in humans concluded that 
autogenous bone graft enables the highest amount of 
newly formed bone compared with the use of bone 
substitutes alone or different compositions of bone 
substitutes and autogenous bone graft [17]. This 
is in accordance with a previous published meta-
analysis demonstrating that MSFA with autogenous 
bone graft generates a significantly higher TBV 
in the early healing period compared with bone 
substitutes alone or different compositions of 
autogenous bone graft and bone substitutes, while 
a non-significant difference was reported after 
a longer observation period [26]. Consequently, 
type and composition of the grafting material as 
well as length of healing period seems to influence 
the histomorphometric outcome. Therefore, the 
objective of the present systematic review and 
meta-analysis was to test the hypothesis of no 
differences in histomorphometric outcomes after 
maxillary sinus floor augmentation with autogenous 
bone graft alone compared with alternate grafting 
materials.
MATERIAL AND METHODS
Protocol and registration
The present systematic review was conducted in 
accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) 
statement for reporting systematic reviews [27]. 
Methods of the analysis and inclusion criteria were 
specified in advance and documented in a protocol 
and registered in PROSPERO, an international 
prospective register of systematic reviews. 
Registration number: CRD42020177003.
The protocol can be accessed at: 
https://www.crd.york.ac.uk/prospero/display_record.
php?ID=CRD42020177003.
Focus question
The focus question was developed according to the 
Patient, Intervention, Comparison and Outcome 
(PICO) framework as described in Table 1:
Are there any differences in the histomorphometric 
outcomes after MSFA with autogenous bone 
graft alone compared with alternate grafting 
materials?
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Types of studies and publications
Randomized controlled trials in humans. 
Population
Included studies involved healthy adult partially 
or totally edentulous patients with atrophy of the 
posterior part of the maxilla receiving MSFA applying 
the lateral window technique with autogenous 
bone graft alone compared with alternate grafting 
materials.
Types of outcome measures
• BIC defined as percentage of bone area in direct 
contact with the implant surface. 
• TBV defined as percentage of bone volume of the 
examined tissue sample.
• BAF defined as percentage of bone area in a 
clearly specified region of interest.
• Percentage of newly formed bone, non-
mineralized tissue and residual graft material 
as evaluated by histomorphometric analysis or 
micro-computed tomography.
Information sources
The search strategy incorporated examinations of 
electronic databases, supplemented by a thorough 
hand-search page by page of relevant journals 
including “British Journal of Oral and Maxillofacial 
Surgery”, “Clinical Implant Dentistry and Related 
Research”, “Clinical Oral Implants Research”, 
“European Journal of Oral Implantology”, “Implant 
Dentistry”, “International Journal of Oral and 
Maxillofacial Implants”, “International Journal of 
Oral and Maxillofacial Surgery”, “International 
Journal of Periodontics and Restorative Dentistry”, 
“International Journal of Prosthodontics”, “Journal 
of Clinical Periodontology”, “Journal of Dental 
Research”, “Journal of Oral Implantology”, “Journal 
of Oral & Maxillofacial Research”, “Journal of 
Periodontology”, “Journal of Prosthetic Dentistry”, 
“Journal of Craniofacial Surgery”, “Journal of 
Cranio-Maxillo-Facial Surgery”, “Journal of Oral 
and Maxillofacial Surgery”, “Periodontology 2000”, 
“Oral and Maxillofacial Surgery” and “Oral Surgery 
Oral Medicine Oral Pathology Oral Radiology”. The 
manual search also included the bibliographies of 
all articles selected for full-text screening as well as 
previously published reviews relevant for the present 
systematic review. 
Search
A MEDLINE (PubMed), Embase, and Cochrane 
Library search was conducted. Human studies 
published in English until the 25th of March, 2020 
were included. Grey literature, unpublished literature 
as well as other databases like Scopus, Google 
Scholar, or Research Gate were not included in the 
search strategy of the present systematic review. 
The search strategy was performed in collaboration 
with a librarian and utilized a combination of 
Medical subject heading (MeSH) and free text terms. 
A detailed description of the search strategy is 
outlined in Appendices 1, 2 and 3.
Selection of studies
PRISMA flow diagram presents an overview of 
the selection process (Figure 1). Titles of identified 
reports were initially screened with duplicates 
removed. Abstracts were assessed when the title 
indicated that the study was relevant. Full-text 
analysis was obtained for those with apparent 
relevance or when the abstract was unavailable. 
References of papers identified and previously 
published systematic reviews were cross-checked for 
unidentified articles. Study selection was performed 
by one reviewer (T.S-J.). 
Inclusion criteria
Studies assessing MSFA with particulated autogenous 
Table 1. PICOS guidelines
Patient and population (P) Healthy adult patients with vertical atrophy of the posterior part of the maxilla receiving maxillary sinus floor augmentation applying the lateral window technique.
Intervention (I) Autogenous bone graft alone.
Comparator or control group (C) Alternate grafting materials.
Outcomes (O) Bone-to-implant contact, total bone volume, bone area fraction, newly formed bone, non-mineralized tissue and residual graft material.
Study design (S) Randomized controlled trials.
Focused question Are there any differences in histomorphometric outcomes after maxillary sinus floor augmentation with autogenous bone graft alone compared with alternate grafting materials?
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bone graft alone compared with alternate grafting 
material were included by addressing the previous 
described outcome measures. The review exclusively 
focused on studies presenting histomorphometric 
outcome. In addition, at least five patients involving 
five sinus augmentation procedures in each group 
should be included and the used grafting material as 
well as number of sinus augmentation procedures had 
to be clearly specified. 
Exclusion criteria
Following exclusion criteria were applied: MSFA 
with autogenous bone block graft, unspecified length 
of observation period as well as studies involving 
medically compromised patients. Moreover, letters, 
editorials, PhD theses, letters to the editor, case 
reports, abstracts, technical reports, conference 
proceedings, animal or in vitro studies and literature 
review papers were also excluded.
Data extraction
Data were extracted by one reviewer (T.S-J.) according 
to a data-collection form ensuring systematic 
recording of the outcome measures. In addition, 
relevant characteristics of the study were recorded. 
Corresponding authors were contacted by e-mail in the 
absence of important information or ambiguities.
Data items
Following items were collected and arranged in the 
following fields: author, year of publication, study 
design, number of patients, MSFA procedures, 
residual alveolar bone height, type of grafting 
material, length of observation period, number of 
biopsies, BIC, bone regeneration including percentage 
of TBV, BAF, newly formed bone, non-mineralized 
tissue and residual graft material. 
Assessment of methodological quality 
Quality assessment was undertaken by one review 
author (T.S-J.) as part of the data extraction process. 
Cochrane Collaboration’s tool for assessing the risk 
of bias suggested in the Cochrane Handbook for 
Systematic Reviews of Interventions was used for 
included randomized controlled trials (version 5.1.0) 
[28]. Following items were evaluated:
• Random sequence generation;
• Allocation concealment;
Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram demonstrating 
the results of the systematic literature search.
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• Patient blinding;
• Outcome blinding;
• Incomplete outcome data addressed;
• Selective reporting.
• Publications were grouped into the following 
categories [29]:
• Low risk of bias (possible bias not seriously 
affecting results) if all criteria were met.
• High risk of bias (possible bias seriously 
weakening reliability of results) if one or more 
criteria were not met.
• Unclear risk of bias when too few details were 
available for classification as high or low risk. 
Statistical analysis
Meta-analysis (with random effect) where conducted 
to combine data from multiple studies where similar 
effects were measured. Results were expressed as the 
mean difference (MD) between autogenous bone graft 
alone compared with alternate grafting materials. The 
95% confidence interval (CI) was also calculated. 
Parametric data are expressed as mean and standard 
deviation (M [SD]). Statistical significance level was 
defined at P = 0.05.
Assessment of heterogeneity
The significance of any discrepancies in the estimates 
of the treatment effects of the different studies was 
assessed by means of Cochran’s test for heterogeneity 
and the I2 statistic, which describes the percentage 
of total variation across studies that is due to 
heterogeneity rather than chance. Heterogeneity by 
Cochran’s test was considered statistically significant 
if P < 0.1. A rough guide to the interpretation of I2 
given in the Cochrane Handbook for Systematic 
Reviews of Interventions is as follows [28]:
• 0 - 40% the heterogeneity might not be important;
• 30 - 60% may represent moderate heterogeneity;
• 50 - 90% may represent substantial heterogeneity;
• 75 - 100% may represent considerable heterogeneity.
RESULTS
Study selection
Article review and data extraction were performed 
according to the PRISMA flow diagram (Figure 1). 
The systematic electronic literature search resulted 
in 1902 entries. No additional articles were identified 
through hand-searching. Of these 1902 articles, 870 
were excluded because they had been retrieved in 
more than one search. A total of 176 abstracts were 
reviewed and full-text analysis included 28 articles. 
Finally, 16 studies were included [30-45]. 
Exclusion of studies
Reasons for excluding studies after full-text 
assessment were as follows: less than five patients 
included [46], less than five sinus augmentation 
procedures in each group [47], controlled clinical 
trials without randomization [48-52], MSFA in 
conjunction with additional augmentation procedures 
[53], alveolar ridge augmentation not involving 
MSFA [54], autogenous bone block graft was used as 
grafting material [55], histomorphometric outcome 
was not expressed in percentage [56], and MSFA was 
conducted with the use of space-maintaining mesh [57]. 
Study characteristics 
Included studies consisted of 16 randomized 
controlled trials with an unclear risk of bias [30-
45]. Partially and totally edentulous patients with 
atrophy of the posterior maxilla were enrolled in the 
included studies. Power calculation was performed 
in three studies [42,44,45]. A split-mouth study 
design was used in seven studies [30,31,33-35,40,41]. 
No significant difference in patient demographics 
was reported in one study [35]. Residual bone 
height as well as inclusion and exclusion criteria 
were clearly specified in all included studies 
[30-45]. Randomization was conducted using a 
randomization table [32,35,40], computer-generated 
randomization code [41], allocation concealment 
process [37], drawing lots [42-45], coin-toss method 
[34], or no information was provided about the 
randomization procedure [30,31,33,36,38,39]. The 
surgical procedure was performed by one surgeon 
[36,39,40,44] or no information was provided about 
the number of surgeons involved [30-35,37,38,41-
43,45]. Autogenous bone graft was harvested from 
the ascending mandibular ramus [31,37,38,40,42-45], 
mandibular symphysis [32,37,42-45], lateral sinus 
wall [41], zygomatic buttress [36,41], tuberosity area 
[39,41] or iliac crest [30,32,33,35]. Autogenous bone 
graft was compared with a synthetic biomaterial 
alone involving BioGran® (3i Implant Innovations, 
Inc.; Palm Beach Gardens, FL, USA) [32,45], 
BoneCeramic® (Straumann AG; Basal, Switzerland) 
[38,39,41], Cerasorb® (Curasan AG; Kleinostheim, 
Deutschland) [34], and chronOS® (Synthes Inc.; West 
Chester, PA, USA) [43] or composite graft consisting 
of 50% BioGran® and 50% autogenous bone graft 
[30,42,44,45] or 50% chronOs® and 50% autogenous 
bone graft [43]. Autogenous bone graft was compared 
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with xenograft alone involving Bio-Oss® (Geistlich 
Pharma AG; Wolhusen, Switzerland) [38], OsteoBiol® 
(Tecnoss Dental s.r.l.; Turin, Italy) [33] or a composite 
xenograft involving 20% Bio-Oss® mixed with 80% 
autogenous bone graft [31]. Autogenous bone graft 
was compared with allogeneic bone graft involving 
Puros® (Zimmer Dental GmbH; Munich, Germany) 
[38] or fresh frozen bone [40]. Autogenous bone 
graft was also compared with platelet-rich plasma 
mixed with autogenous bone graft [35,37] or blood 
coagulum including replacement of the lateral bone 
window or barrier membrane coverage of the lateral 
window [36]. Different collagen barrier membranes 
were used to cover the lateral window involving Bio-
Gide® (Geistlich Pharma AG; Wolhusen, Switzerland) 
[31,38-40], Tecnoss® (Tecnoss Dental s.r.l.; Torino, 
Italy) [33], Spongostan® film (Johnson & Johnson 
Medical N.V.; Courcelles, Belgium) [36], type of 
membrane was not specified [37,41], no information 
was provided about the use of a membrane [30,35,42-
45] or no membrane was used [32,34]. None of the 
membranes were fixed with tacks. Experimental 
micro-implants were retrieved for assessment of BIC 
after six [31] and seven months [36]. MSFA with 
simultaneous implant placement was performed in 
one study [36], while delayed implant placement was 
conducted after four months [30,37], five months 
[30,33,38], six months [30-32,34,35,37,40-45], 
nine months [39] or 16 months [30], respectively. 
Different implant systems were used including 
Ankylos® (Dentsply Implants Manufacturing GmbH; 
Mannheim, Germany) [34], Conexão System® 
(Gestão de TI e Impressão; São Paulo, Brazil) [40], 
Nobel Biocare® (Nobel Biocare AB; Gothenburg, 
Sweden) [31], Premium TG® (Sweden & Martina 
SpA; Padova, Italy) [33], Protetim® (Protetim Orvosi 
Műszergyártó Kft.; Hódmezővásárhely, Hungary) 
[34], Spectra-System® (Core-Vent Corporation, Las 
Vegas, NV, USA) [37], Straumann® (Straumann AG; 
Basal, Switzerland) [32,36,38,39,41], whereas the 
used implant system was not specified in six studies 
[30,35,42-45]. Histomorphometric assessment 
involving micro-computed tomography was 
performed after six months [45] and seven months 
[36], respectively. Tissue specimens were evaluated 
after four months [30,37], five months [30,33,38], 
six months [30-32,34,35,37,40-45], nine months 
[39] and 16 months [30], respectively. Number of 
biopsies were clearly specified in eight studies [30-
36,40], while no information was provided in seven 
studies [37,39,41-45]. Bone cores were retrieved with 
trephine drill through the previous lateral window 
[31,32,40,41], at planed implant site [30,33,34,38,39], 
or not specified [35-37,42-45]. Percentage of BIC was 
evaluated in two studies [31,36]. Percentage of TBV 
was assessed in seven studies [30,32-35,37,45], BAF 
in three studies [31,38,39], and percentage of newly 
formed bone was estimated in five studies [40-44]. 
None of the included studies provided information 
about blinding, training or calibration of surgeons or 
the examiners assessing the clinical and radiographic 
outcome. Numbers of drop-outs were reported in three 
studies [43-45]. 
Outcome measures
BIC, TBV, BAF and newly formed bone are 
considered the primary outcome measures, while 
non-mineralized tissue and residual graft materiel are 
surrogate outcome. Percentage of non-mineralized 
tissue and residual graft materiel are therefore solely 
presented in Table 2. Results of each primary outcome 
are described below including a short summary and 
outlined in Table 2.
Bone-to-implant contact
Percentage of BIC with autogenous bone graft 
compared with mixture of 80% Bio-Oss® and 20% 
autogenous bone graft were 34.6 (9.5) and 54.3 (33.1) 
after six to seven months, respectively [31]. There was 
no significant difference (P > 0.05) [31]. 
Percentage of BIC with autogenous bone graft 
compared with blood coagulum including either 
replacement of the lateral bone window or barrier 
membrane coverage were 93.5 (3.3), 93.5 (3.3) and 92 
(4.1) after seven months, respectively [36]. There was 
no significant difference (P = 0.502) [36]. 
Summary
BIC after MSFA with autogenous bone graft was 
comparable to alternate grafting material consistent 
of 80% xenograft mixed with 20% autogenous bone 
graft or blood coagulum. 
Total bone volume 
Percentage of TBV with autogenous bone graft was 
40.9 (3.3), 42.2 (4.5), 43.7 (2.4), and 45.1 (38.1) 
after four, five, six, and 16 months, respectively [30]. 
Corresponding measurements for 50% BioGran® and 
50% autogenous bone graft were 28.5 (1.4), 34.5 
(1.6), 38.1 (5.7), and 44.5. No statistically analysis 
was performed [30].
Percentage of TBV with autogenous bone graft 
compared with Cerasorb® was 41 (10) and 
17.5 (5) after six months, respectively [32]. 
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Table 2. Histomorphometric outcomes after maxillary sinus floor augmentation with autogenous bone graft compared with alternate grafting materials
Study Year ofpublication
Number 
of 
patients
Materials and methods Outcome measures
Maxillary 
sinus floor 
augmentation
RBH
(mm) Type of grafting material
Length of
observation period
(months)
Number 
of 
biopsies
Bone-to-implant 
contact 
(%)
Bone regeneration
TBV, BAF or NFB Non-mineralized tissue Residual graft
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Tadjoedin et al. [30] 2000 10
10
< 3 
50% Biogran®; 50% autogenous
4 - 16
36
NR
4 month 5 month 6 month 16 month
NR NR28.5 (1.4) 34.5 (1.6) 38.1 (5.7) 44.5
10 Autogenous 36 40.9 (3.3) 42.2 (4.5) 43.7 (2.4) 45.1
Hallman et al. [31] 2002 21
11
< 5 
20% Bio-Oss®; 80% autogenous
6.5
8 54.3 (33.1) 39.9 (8)
NR
12.3 (8.5)
11 Autogenous 8 34.6 (9.5) 37.7 (31.3) NR
Zerbo et al. [32] 2004 9
9
4 - 8
Cerasorb®
6
32
NR
17 (5)
NR NR
5 Autogenous 18 41 (10)a
Barone et al. [33] 2005 18
18
< 3
OsteoBiol®
5 NR NR
67 (14.9)
NR NR
18 Autogenous 70 (19.9)
Szabó et al. [34] 2005 20
20
< 5 
Cerasorb®
6
40
NR
36.5 (6.9)
NR NR
20 Autogenous 40 38.3 (7.4)
Bettega et al. [35] 2009 18
9 3 Autogenous mixed with PRP
6
9
NR
43.2
NR NR
9 3.5 Autogenous 9 50
Johansson et al. [36] 2013 24
10 4.3 Bloodclot
7
10 93.5 (3.3)
NR NR NR10 3.5 Bloodclot and membrane 9 92 (4.1)
10 4.3 Autogenous 10 93.5 (3.3)
Khairy et al. [37] 2013 15
10
< 5
Autogenous mixed with PRP 4 - 6
NR NR
4 month 6 month
NR NR27.3 (6.3) 28 (4.1)
5 Autogenous 6 NR 39.5 (7.4)b
Schmitt et al. [38] 2013 30 45
2.3 BoneCeramic®
5
14
NR
30.3 (2.2) 55.2 (5.6) 15.2 (2.1)
2.5 Bio-Oss® 15 24.9 (5.7) 53.7 (8.1) 21.4 (4.8)
2.6 Puros® 12 35.4 (2.8) 64.6 (2.8)
NR
2.2 Autogenous 12 42.7 (2.1)c 57.3 (2.1)
Tosta et al. [39] 2013 30
15
4.1
BoneCeramic®
9 NR NR
Intermediate Apical Intermediate Apical
NR33.7 (8.1) 26.7 (3.9) 33.4 (8) 39.6 (11.1)
15 Autogenous  41 (4.6)d  38.6 (7.5)e 59.2 (4.7)f 60.6 (7.2)g
Xavier et al. [40] 2015 15
15
≤ 3
Fresh frozen bone
6
15
NR
8.3 (3) 56.8 (7.3) 34.9 (6.4)
15 Autogenous 15 8.3 (3.4) 55.6 (14.5) 36.1 (12.8)
Danesh-Sani et al. [41] 2016 10
10
< 5
BoneCeramic®
6 - 8
10
NR
28.2 (8.4) 38.9 (14.9) 32.9 (8.1)
10 Autogneous 10 36.8 (11.5)h 58.4 (10)i  4.8 (2.4)j
Pereira et al. [42] 2017 30
10
< 5
Biogran®
6 NR NR
Intermediate Apical Intermediate Apical
NR
40.7 (14) 45.6 (13.5) 56.6 (15.3) 47.9 (12.1)
10 50% Biogran®; 50% autogenous 33.2 (13.3) 45.8 (13.9) 62.5 (14.7) 48.8 (17.7)
10 Autogenous 35.3 (14.7) 39.9 (15.8) 61.2 (15.7) 57.8 (16.2)
Pereira et al. [43] 2017 22
12
< 5
chronOS®
6 NR NR
Intermediate Apical Intermediate Apical
NR
47.6 (9.9) 44.8 (22.1) 52.3 (9.9) 55.1 (22.1)
12 50% chronOS®; 50% autogenous 32.5 (13.7) 32.8 (16) 60.1 (13.9) 55.5 (9.2)
12 Autogenous 31 (13) 46.1 (16.3) 65 (10.2) 50.2 (14.5)
Menezes et al. [44] 2018 21
14
< 5
50% Biogran®;
50% autogenous 6 NR NR
Intermediate Apical
NR NR33.2 (13.3) 45.8 (13.8)
13 Autogenous 35 (13.9) 42 (16.6)
Pereira et al. [45] 2018
10 12
< 5
Biogran®
6 NR NR
52.1
NR NR7 9 50% Biogran®; 50% autogenous 57.4
10 12 Autogenous bone 57.2
aP < 0.05 (Independent t-test); bP = 0.003 (Paired t-test); cP = 0.0001 (Kruskal-Wallis test); dP = 0.008 (Mann-Whitney test); eP < 0.0001 (Mann-Whitney test); fP < 0.0001 (Mann-Whitney test); gP < 0.0001 (Mann-Whitney test); hP = 0.0032 (Paired t-test); iP = 0.0001 (Paired t-test); jP < 0.0001 (Paired t-test).
BAF = bone area fraction; NFB = newly formed bone; NMT = non-mineralized tissue; PRP = platelet rich plasma; RBH = residual bone height; RCT = randomized controlled trial; SD = standard deviation; TBV = total bone volume.
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The difference was significant demonstrating higher 
TBV with autogenous bone graft (P = 0.05) [32]. 
Percentage of TBV with autogenous bone graft 
compared with OsteoBiol® was 70 (19.9) and 67 
(14.9) after five months, respectively [33]. There was 
no significant difference (P > 0.05) [33]. 
Percentage of TBV with autogenous bone graft 
compared with Cerasorb® were 38.3 (7.4) and 36.5 
(6.9) after six months, respectively [34]. There was no 
significant difference (P = 0.25) [34]. 
Percentage of TBV with autogenous bone graft 
compared with platelet-rich plasma mixed with 
autogenous bone graft was 50 (range 38 to 70) and 
43.2 (range 40 to 54.8) after six months, respectively 
[35]. There was no significant difference (P = 0.474) 
[35]. 
Percentage of TBV with autogenous bone graft was 
39.5 (7.4) after six months [37]. Corresponding 
measurements for platelet-rich plasma mixed with 
autogenous bone graft were 27.3 (6.3) and 28 (4.1) 
after four and six months, respectively. The difference 
was significant demonstrating higher TBV with 
autogenous bone graft (P = 0.003) [37]. 
Percentage of TBV with autogenous bone graft 
compared with mixture of 50% Biogran® and 50% 
autogenous bone graft or Biogran® alone were 52.1, 
57, and 57.2 after six months, respectively [41]. There 
was no significant difference (P > 0.05) [45].
Summary
TBV after MSFA with autogenous bone graft 
was comparable with alternate grafting materials 
consistent of synthetic bone graft or xenograft alone 
as well as autogenous bone graft mixed with synthetic 
bone graft or platelet-rich plasma. However, TBV 
was statistically significant higher with autogenous 
bone graft compared with synthetic bone graft alone 
or platelet-rich plasma mixed with autogenous bone 
graft in other studies with similar observation period. 
Thus, percentage of TBV seems to be equivalent or 
enhanced after MSFA with autogenous bone graft 
compared with alternate grafting materials. 
Bone area fraction
Percentage of BAF with autogenous bone graft 
compared with mixture of 80% Bio-Oss® and 20% 
autogenous bone graft was 37.7 (31.3) and 39.9 (8) 
after six months, respectively [31]. There was no 
significant difference (P > 0.05) [31]. 
Percentage of BAF with autogenous bone graft was 
42.7 (2.1) after five months [38]. Corresponding 
measurement for BoneCeramic®, Bio-Oss® 
and Puros® were 30.3 (2.2), 24.9 (5.7) and 35.4 
(2.8), respectively. The difference was significant 
demonstrating higher BAF with autogenous bone 
graft compared with BoneCeramic® (P < 0.000) and 
Bio-Oss® (P < 0.000) [38].
Percentage of BAF with autogenous bone graft 
compared with BoneCeramic® in the intermediate 
region of the biopsies were 41 (4.6) and 33.7 (8.1) 
after nine months, respectively [39]. Corresponding 
measurements in the apical region of the biopsies 
were 38.6 (7.5) and 26.7 (3.9). The difference 
was significant demonstrating higher BAF with 
autogenous bone graft in the intermediate region 
(P = 0.008) and apical region (P < 0.001), respectively 
[39]. 
Summary
BAF after MSFA with autogenous bone graft 
was comparable with alternate grafting materials 
consistent of allogeneic bone graft alone and 
autogenous bone graft mixed with xenograft. 
However, BAF was statistically significant higher 
with autogenous bone graft compared with synthetic 
bone graft or xenograft alone in other studies with 
similar observation period. Thus, percentage of BAF 
seems to be equivalent or enhanced after MSFA 
with autogenous bone graft compared with alternate 
grafting materials.
Newly formed bone
Percentage of newly formed bone with autogenous 
bone graft compared with fresh frozen bone were 8.3 
(3.4) and 8.3 (3) after six months, respectively [40]. 
There was no significant difference (P > 0.05) [40]. 
Percentage of newly formed bone with autogenous 
bone graft compared with BoneCeramic® were 36.8 
(11.5) and 28.2 (8.4) after six months, respectively 
[41]. The difference was significant demonstrating 
more newly formed bone with autogenous bone graft 
(P = 0.0032) [41]. 
Percentage of newly formed bone with autogenous 
bone graft compared with mixture of 50% Biogran® 
and 50% autogenous bone graft or Biogran® alone 
in the intermediate region of the biopsies were 35.3 
(14.7), 33.2 (13.3), and 40.7 (14) after six months, 
respectively [42]. Corresponding measurements in 
the apical region of the biopsies were 39.9 (15.8), 
45.8 (13.9), and 45.6 (13.5). There was no significant 
difference between the different graft compositions in 
either the intermediate or apical region of the biopsies 
(P > 0.05) [42]. 
Percentage of newly formed bone with autogenous 
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bone graft compared with mixture of 50% chronOS® 
and 50% autogenous bone graft or chronOS® alone 
in the intermediate region of the biopsies were 31 
(13), 32.5 (13.7), and 47.6 (9.9) after six months, 
respectively [43]. Corresponding measurements in 
the apical region of the biopsies were 46.1 (16.3), 
32.8 (16), and 44.8 (22.1). There was no significant 
difference in either the intermediate or apical region 
of the biopsies between the two treatment modalities 
(P > 0.05) [43]. 
Percentage of newly formed bone with autogenous 
bone graft compared with mixture of 50% Biogran® 
and 50% autogenous bone graft in the intermediate 
region of the biopsies were 35 (13.9) and 33.2 (13.3) 
after six months, respectively [44]. Corresponding 
measurements in the apical region of the biopsies 
were 42 (16.6) and 45.8 (13.8). There was no 
significant difference in either the intermediate or 
apical region of the biopsies between the two 
treatment modalities (P > 0.05) [44]. 
Summary
Percentage of newly formed bone after MSFA with 
autogenous bone graft was comparable with alternate 
grafting materials consistent of allogeneic bone 
graft or synthetic biomaterials and autogenous bone 
graft mixed with synthetic biomaterials. However, 
percentage of newly formed bone was statistically 
significant higher with autogenous bone graft 
compared with synthetic biomaterials in other studies 
with similar observation period. Thus, percentage of 
newly formed bone seems to be equivalent or higher 
after MSFA with autogenous bone graft compared 
with alternate grafting materials.
Meta-analysis
A meta-analysis can only be conducted for continuous 
data if both the mean and standard deviation 
are available. Thirteen studies met the inclusion 
requirement for the meta-analysis [30-34,37-44], 
and the remaining three studies [35,36,45] were 
excluded. However, the included studies of the meta-
analysis revealed variations in study design, i.e. 
residual height of the alveolar process, harvesting 
of autogenous bone graft from dissimilar locations, 
with or without barrier membrane coverage of the 
lateral window, number of biopsies, bone cores for 
histomorphometric analysis were retrieved at different 
locations, and histomorphometric parameters were 
presented differently. A forest plot was drawn to 
show a summary of total amount of bone including 
values of TBV, BAF and newly formed bone, 
respectively. Solely values retrieved from the apical 
part of the biopsies were included in the meta-
analysis, when histomorphometric outcome from 
both the intermediate and apical part of the biopsy 
were reported [39,42-44]. Random effect analysis 
and test for heterogeneity was inconclusive due to 
the limited number of studies included. Statistically 
significant difference in heterogeneity between the 
included studies was found for allogeneic bone graft 
(I2 = 96.92%, P = 0.001) [38,40], xenograft (I2 = 
83.95%, P = 0.01) [33,38] and synthetic biomaterials 
(I2 = 92.01%, P = 0.001) [32,34,38,39,41-44]. 
Studies assessing synthetic biomaterials mixed 
with autogenous bone graft disclosed substantial 
heterogeneity (I2 = 66.9%, P = 0.11) [30,42,43]. 
Meta-analysis revealed an overall mean difference of 
-7.1% (95% CI = -11 to -3.2) indicating a statistically 
significant higher amount of bone after MSFA with 
autogenous bone graft alone compared with alternate 
grafting materials. Subgroup analysis disclosed a 
non-significantly differences of -3.7% (95% CI = 
-10.9 to 3.4), -11.5% (95% CI = -25.9 to 2.8), 2.2% 
(95% CI = -16.9 to 21.3), and -4.6% (95% CI = 
-14.4 to 5.2), when autogenous bone graft alone was 
compared with allogeneic bone graft, xenograft, 
composite grafting materials involving xenograft or 
synthetic biomaterial mixed with autogenous bone 
graft, respectively (Figure 2).
A funnel plot of the included studies is presented 
(Figure 3). Larger studies with higher power are 
placed towards the top (smaller standard errors), while 
lower powered studies are placed towards the bottom. 
Eggers test did not indicate small-study effects 
(P = 0.08).
Quality assessment
The quality of the included studies is summarized in 
Table 3. All the included studies were characterized 
by unclear risk of bias [30-45]. 
DISCUSSION
The objective of the present systematic review 
and meta-analysis was to test the hypothesis of 
no difference in histomorphometric outcomes 
after MSFA with autogenous bone graft alone 
compared with alternate grafting materials. The 
electronic search and hand-searching resulted in 
1068 entries after duplicates have been removed. 
Sixteen randomized controlled trials with 
unclear risk of bias fulfilled inclusion criteria 
and were included in the final synthesis [30-45]. 
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Figure 2. Meta-analysis using a random effect model assessing total amount of bone after maxillary sinus floor augmentation with autogenous 
bone graft alone compared with alternate grafting materials.
Descriptive statistics demonstrated that the percentage 
of BIC, TBV, BAF and newly formed bone were 
equivalent or higher with autogenous bone graft 
compared with alternate grafting materials [30-45]. 
Meta-analysis demonstrated significantly improved 
histomorphometric outcomes after MSFA with 
autogenous bone graft compared with alternate 
grafting materials. However, subgroup analysis 
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Table 3. Quality assessment of included studies
Author Random sequence generation
Allocation 
concealment
Patient 
blinding
Outcome 
blinding
Incomplete outcome
data addressed
Selective 
reporting
Tadjoedin et al. [30] + ? ? ? + +
Hallman et al. [31] + ? ? ? + +
Zerbo et al. [32] + + ? ? + +
Barone et al. [33] + ? ? ? + +
Szabó et al. [34] + ? ? ? + +
Bettega et al. [35] + ? ? ? + +
Johansson et al. [36] + ? ? ? + +
Khairy et al. [37] + + ? ? + +
Schmitt et al. [38] + ? ? ? + +
Tosta et al. [39] + ? ? ? + +
Xavier et al. [40] + ? ? ? + +
Danesh-Sani et al. [41] + ? ? ? + +
Pereira et al. [42] + ? ? ? + +
Pereira et al. [43] + ? ? ? + +
Menezes et al. [44] + ? ? ? + +
Pereira et al. [45] + ? ? ? + +
+ = low risk of bias; ÷ = high risk of bias; ? = unclear risk of bias.
Figure 3. Funnel plot to visualized heterogenicity among the included studies. Larger studies with higher power are placed towards the top 
(smaller standard errors) and lower powered studies towards the bottom. An asymmetry in the funnel plot indicate bias. Eggers test did not 
indicate small-study effects (P-value = 0.08).
revealed a non-significantly differences, when 
autogenous bone graft was compared with allogeneic 
bone graft or xenograft as well as composite 
grafting materials consist of xenograft or synthetic 
biomaterial mixed with autogenous bone graft. The 
included studies presented to some extent opposing 
results and conclusions drawn from the results of the 
present systematic review and meta-analysis should 
therefore be interpreted with caution. Moreover, 
histomorphometric outcomes after MSFA are 
influences by various confounding factors including 
sinus cavity dimensions, size of the lateral window, 
barrier membrane coverage of the lateral window, 
and retrievement of bone cores for histomorphometric 
analysis at different locations [58-61]. Varying degree 
of heterogeneity according to these parameters 
were present among the included studies [30-
45]. Thus, the histomorphometric outcomes of 
the present systematic review are not factual 
comparable and influenced by various methodological 
confounding factors, which has not been 
assessed. 
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Osseointegration is defined as a direct structural 
and functional connection between living bone 
and the surface of a load-carrying implant [62]. 
Placement of implants in pristine or augmented 
bone elicits a sequence of biological events at the 
bone-to-implant interface, which influence the 
degree of osseointegration and percentage of BIC 
[63-65]. Numerous factors seem to enhance or 
inhibit osseointegration during the healing process 
including bone quality and quantity, implant surface 
characteristics and intrinsic healing potential [63-
65]. Establishment of osseointegration and BIC of 
50 - 80% are considered as a prerequisite for implant 
loading and long-term implant survival [17,65,66]. 
The ideal grafting material for MSFA should therefore 
ensure the highest BIC within the shortest healing 
period. Autogenous bone graft accelerates bone 
regeneration due to its osteoinductive, osteogenic and 
osteoconductive characteristics, while bone substitutes 
solely provide an osteoconductive framework and 
relies on recruitment and migration of osteogenic 
cells to the implant surface. Thus, from a theoretical 
point of view, autogenous bone graft alone or in 
combination with a bone substitute are expected to 
facilitate a higher percentage of BIC compared with 
bone substitute alone, which have been demonstrated 
in an experimental study revealing statistically 
significantly higher BIC values after MSFA with 
autogenous bone graft alone or in combination with 
different ratios of xenograft compared with xenograft 
alone [23]. However, none of the included studies 
of the present systematic review reported a higher 
percentage of BIC with autogenous bone graft alone 
compared with alternate grafting materials [31,36]. 
Moreover, BIC was considerably lower after MSFA 
with autogenous bone graft alone compared with 
mixture of autogenous bone graft and xenograft 
[31]. A previous published systematic review in 
animals concluded that BIC increases with the length 
of the observation period, but a healing period of 
more than eight months seemed not to improve BIC 
substantially in conjunction with MSFA [67]. In the 
present systematic review, BIC was assessed after 6.5 
months and seven months, respectively [31,36]. In 
conclusion, MSFA with autogenous bone graft alone 
seems not to significantly improve percentage of BIC 
compared with alternate grafting materials. Though, 
this assumption should be interpreted with caution, 
since only two studies assessing BIC were included in 
the present systematic review [31,36]. 
Histological analysis present qualitative data of bone 
regeneration, while histomorphometric analysis 
focuses on the quantitative data. Percentage of TBV, 
BAF and newly formed bone are commonly used 
for quantitatively assessment of mineralization in 
conjunction with alveolar ridge augmentation [17]. 
The included studies of the present systematic review 
demonstrated that the percentage of TBV, BAF and 
newly formed bone after MSFA with autogenous 
bone graft alone varied between 37.7% to 70% [30-
35,37-45]. Corresponding measurements for synthetic 
biomaterials, xenograft and allogeneic bone graft were 
17 - 52.1% [32,34,38,41-45], 24.9 - 67% [33,38], 
and 8.3 - 35.4% [38,40], respectively. Values for 
composite grafting materials including autogenous 
bone graft mixed with different ratios of synthetic 
biomaterials, xenograft or platelet-rich plasma were 
28.5 - 57.4% [30,42-45], 39.9% [31], and 28 - 43.2% 
[35,37], respectively. Descriptive statistics seems 
to indicate that percentage of TBV, BAF and newly 
formed bone after MSFA with autogenous bone graft 
alone is comparable or higher compared with alternate 
grafting materials, which is in accordance with 
conclusion of a previous systematic review and meta-
analysis [17]. 
Microcomputed tomography analysis of bone 
biopsies harvested in the pristine non-atrophic 
posterior maxilla have demonstrated a mean 
bone volume fraction of 51.9% (28.4) [68]. A 
previous study comparing bone biopsies obtained 
from pristine non-atrophic posterior maxilla with 
biopsies from the augmented region after MSFA 
with autogenous bone graft mixed with xenograft 
revealed no statistically significant difference in 
histomorphometric outcomes [69]. These results are 
in accordance with the present systematic review 
disclosing no statistically significant differences in 
the histomorphometric outcomes between pristine 
bone compared with the intermediate or apical region 
after MSFA with autogenous bone graft, synthetic 
biomaterials or autogenous bone graft mixed with 
synthetic biomaterials, after six months [42-44]. 
However, a statistically significant higher percentage 
of mineralized bone was reported in the pristine 
bone region compared with the augmented region 
after MSFA with a synthetic biomaterial, whereas 
no significant differences was revealed with the use 
of autogenous bone graft, after nine months [39]. 
The histomorphometric outcome after MSFA with 
autogenous bone graft alone or in combination with 
a bone substitute seems therefore comparable with 
pristine bone. 
A systematic review is a detailed and comprehensive 
search strategy of published literature, which attempts 
to gather all available empirical research by using 
clearly defined, systematic methods to obtain answers 
to a well-defined research question. Meta-analysis 
is the statistical synthesis for meticulous analysing 
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and combining the numerical data withdrawal from 
comparable studies. The strength of evidence from 
a systematic review and meta-analysis is therefore 
related to the quality of the included studies. The 
histomorphometric outcomes of the present systematic 
review and meta-analysis are based on randomized 
controlled trials with an unclear risk of bias and 
various methodological confounding factors [30-
45]. Consequently, the current level of evidence is 
inadequate to propose specified implications for 
evidence based clinical guidelines according to the 
focus question of the present systematic review, 
though MSFA with autogenous bone graft alone seems 
to improve histomorphometric outcomes compared 
with alternate grafting materials. 
CONCLUSIONS
The present systematic review and meta-analysis 
revealed a statistically significant difference in 
histomorphometric outcome after maxillary sinus 
floor augmentation with autogenous bone graft 
alone compared with alternate grafting materials. 
Autogenous bone graft alone or in combination with 
a bone substitute is therefore considered to be the 
optimal grafting material for maxillary sinus floor 
augmentation. Bone substitutes alone seem to be a 
valid alternative, when harvesting of autogenous bone 
graft is not an option. However, the included studies 
of the present systematic review are characterised by 
an unclear risk of bias and various methodological 
confounding factors. Hence, the conclusions drawn 
from the results of the present systematic review 
should be interpreted with caution. 
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augment*[Text Word]))) OR ((sinus floor elevat*[Text Word] OR sinus elevat*[Text Word] OR sinus 
lift*[Text Word])))) AND (((((“Bone Transplantation”[Mesh:NoExp]) OR bone transplant*[Text Word]) OR 
((Autolog*[Text Word] OR autogen*[Text Word]))) OR graft*[Text Word]) OR “Bone Substitutes”[Mesh])
1994
#43 Add Search ((((“Bone Transplantation”[Mesh:NoExp]) OR bone transplant*[Text Word]) OR ((Autolog*[Text Word] OR autogen*[Text Word]))) OR graft*[Text Word]) OR “Bone Substitutes”[Mesh] 501964
#42 Add Search “Bone Substitutes”[Mesh] 9402
#29 Add Search graft*[Text Word] 388892
#26 Add Search (Autolog*[Text Word] OR autogen*[Text Word]) 134804
#24 Add Search bone transplant*[Text Word] 31239
#23 Add Search “Bone Transplantation”[Mesh:NoExp] 30739
#11 Add
Search ((“Sinus Floor Augmentation”[Mesh]) OR ((sinus augment*[Text Word] OR sinus floor 
augment*[Text Word]))) OR ((sinus floor elevat*[Text Word] OR sinus elevat*[Text Word] OR sinus 
lift*[Text Word]))
2742
#10 Add Search (sinus floor elevat*[Text Word] OR sinus elevat*[Text Word] OR sinus lift*[Text Word]) 1756
#8 Add Search (sinus augment*[Text Word] OR sinus floor augment*[Text Word]) 1921
#7 Add Search “Sinus Floor Augmentation”[Mesh] 1092
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Appendix 3. Cochrane Library search until the 25th of March, 2020
ID Search Hits
#1 MeSH descriptor: [Sinus Floor Augmentation] this term only 143
#2 (sinus augment* OR sinus floor augment* OR sinus floor elevat* OR sinus elevat* OR sinus lift*):ti,ab,kw 896
#3 #1 OR #2 896
#4 MeSH descriptor: [Bone Transplantation] this term only 855
#5 MeSH descriptor: [Bone Substitutes] explode all trees 531
#6 (Autolog* OR autogen* OR graft* OR bone transplant*):ti,ab,kw 41416
#7 #4 OR #5 OR #6 41539
#8 #3 AND #7 410
